# The Role of R-Alpha Lipoic Acid in the Treatment of Atherosclerotic Vascular Disease

> **NCT00764270** · PHASE2,PHASE3 · COMPLETED · sponsor: **Oregon State University** · enrollment: 28 (actual)

## Conditions studied

- Atherosclerosis

## Interventions

- **DIETARY_SUPPLEMENT:** R-alpha lipoic acid

## Key facts

- **NCT ID:** NCT00764270
- **Lead sponsor:** Oregon State University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-08-01
- **Primary completion:** 2011-11-01
- **Final completion:** 2024-10-01
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2025-04-11

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00764270

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00764270, "The Role of R-Alpha Lipoic Acid in the Treatment of Atherosclerotic Vascular Disease". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT00764270. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*